Upconversion nanocomposite for programming combination cancer therapy by precise control of microscopic temperature

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Combined chemotherapy (CT) and photothermal therapy (PTT) show promise for cancer treatment.
• The optimal scheduling sequence for CT and PTT remains underexplored.
• Controlling the sequence of CT and PTT is crucial for maximizing therapeutic benefits.

Purpose of the Study:

• To develop a temperature-sensitive upconversion nanocomposite for controlled CT-PTT combination therapy.
• To investigate the impact of administration sequence on therapeutic efficacy.
• To establish a programmed approach for optimizing cancer treatment strategies.

Main Methods:

• Design of a temperature-sensitive upconversion nanocomposite.
• Utilizing upconversion luminescence for microscopic temperature monitoring.
• Implementing a sequence of CT followed by PTT triggered by temperature.
• Comparing therapeutic effects across different administration sequences.

Main Results:

• The developed nanocomposite enables precise temperature monitoring and control.
• Administering CT before PTT demonstrated superior therapeutic effects compared to other sequences.
• Dosage of chemodrug and heat were kept consistent across tested sequences.

Conclusions:

• A programmed sequence of CT followed by PTT, enabled by smart nanocomposites, enhances combination cancer therapy.
• This strategy optimizes the utilization of both chemotherapy and photothermal therapy.
• The findings contribute to the development of advanced cancer treatment modalities.